Neoleukin Therapeutics Inc (NLTX)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE, WA 98102

Neoleukin is a biopharmaceutical company creating next generation immunotherapies for cancer, inflammation and autoimmunity using de novo protein design technology. Neoleukin uses sophisticated computational methods to design proteins that demonstrate specific pharmaceutical properties that provide potentially superior therapeutic benefit over native proteins. Neoleukin's lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to improve tolerability and activity by eliminating the alpha receptor binding interface.

Data as of 2021-07-19 09:17:34 -0400
Market Cap356.974 Million Shares Outstanding42.346 Million Avg 30-day Volume180.077 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-0.5 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.27103 52-week High/Low17.95 / 8.19 Next Earnings Date2021-08-09 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud

Are you looking for this stock instead?

View SEC Filings from NLTX instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
No data found for this quarter.
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding NLTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NLTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

50 Thousand total shares from 2 transactions

Open Market Sells (S)

3.1 Thousand total shares from 5 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WALKEY CARL SENIOR VICE PRESIDENT

  • Officer
1,352,489 2021-06-16 26

DRACHMAN JONATHAN G PRESIDENT AND CEO

  • Officer
  • Director
2,248,686 2021-06-03 2

SIMPSON TODD E

  • Director
25,000 2021-05-11 1

BAKER BROS. ADVISORS LP

667, L.P.

BAKER BROS. ADVISORS (GP) LLC

BAKER BROTHERS LIFE SCIENCES LP

BAKER FELIX

BAKER JULIAN

  • Director
25,000 2021-05-11 1

NOONBERG SARAH B.

  • Director
25,000 2021-05-11 1

WILLIAMS LEWIS T

  • Director
25,000 2021-05-11 1

LAVELLE ERIN M.

  • Director
25,000 2021-05-11 1

BABLER MARTIN

  • Director
25,000 2021-05-11 3

PATEL PRITI CHIEF MEDICAL OFFICER

  • Officer
0 2021-04-30 2

HO ROBERT CHIEF FINANCIAL OFFICER

  • Officer
99,503 2021-03-16 2

VANCE HOLLY GENERAL COUNSEL

  • Officer
0 2020-10-19 2

NOLAN SEAN P.

  • Director
0 2020-05-05 0

REDMILE GROUP, LLC

GREEN JEREMY

  • 10% Owner
4,041,211 2020-03-27 0

BOYD META CANTEY

  • Director
0 2019-08-08 0

ALAM KAMRAN CFO, VICE PRESIDENT FINANCE

  • Officer
0 2018-08-07 0

MACKENZIE LLOYD CHIEF OPERATING OFFICER

  • Officer
0 2018-08-07 0

MAIN DAVID PRESIDENT AND CEO

  • Officer
  • Director
0 2018-08-07 0

MCCLOSKEY SHELLEY VP, HR AND ADMINISTRATION

  • Officer
0 2018-08-07 0

LEVITT DANIEL J

  • Director
0 2018-05-14 0

BRIDGER GARY

  • Director
0 2018-05-07 0

PELZER ROBERT

  • Director
0 2018-05-07 0

JENKINS ABIGAIL CHIEF COMMERCIAL OFFICER

  • Officer
0 2018-03-09 0

TROUPIN BARBARA CHIEF MEDICAL OFFICER

  • Officer
0 2018-03-09 0

LEVY RICHARD S

  • Director
0 2017-03-23 0

NEU KELVIN

  • Director
36 2017-03-23 0

MITCHELL DAVID CHILTON VP GLOBAL REGULATORY & QUALITY

  • Officer
0 2017-03-08 0

BAKER BROS. ADVISORS LP

BAKER BROS. ADVISORS (GP) LLC

BAKER FELIX

BAKER JULIAN

  • 10% Owner
10,938,674 2017-01-09 0

SHREWSBURY STEPHEN B CMO; SENIOR VP CLINICAL DEV.

  • Officer
0 2016-03-10 0

JOHNSON & JOHNSON

JOHNSON & JOHNSON INNOVATION - JJDC, INC.

  • 10% Owner
No longer subject to file 2015-08-10 0

PFIZER INC

  • 10% Owner
No longer subject to file 2015-08-10 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

WALKEY CARL - Officer SENIOR VICE PRESIDENT

2021-06-17 21:46:03 -0400 2021-06-16 S 600 $10.19 d 1,352,489 direct yes -0.6897 0.9852 0.9852 6 -1.6749 4

WALKEY CARL - Officer SENIOR VICE PRESIDENT

2021-06-11 16:13:13 -0400 2021-06-09 S 650 $10.82 d 1,353,089 direct yes -3.305 -4.8159 0.0 1 -5.0992 3

WALKEY CARL - Officer SENIOR VICE PRESIDENT

2021-06-09 17:22:16 -0400 2021-06-08 S 600 $11.00 d 1,353,739 direct yes -2.1637 -3.4807 -24.6472 0.0 1 -24.6472 31

WALKEY CARL - Officer SENIOR VICE PRESIDENT

2021-06-07 17:07:10 -0400 2021-06-04 S 600 $10.00 d 1,354,339 direct yes -3.2407 -5.1852 -21.5741 0.0 1 -23.4259 29

DRACHMAN JONATHAN G - Director - Officer PRESIDENT AND CEO

2021-06-07 17:06:19 -0400 2021-06-04 P 10,000 $9.61 a 2,248,686 direct -3.2407 -5.1852 -21.5741 0.0 1 -23.4259 29

DRACHMAN JONATHAN G - Director - Officer PRESIDENT AND CEO

2021-06-07 17:06:19 -0400 2021-06-03 P 40,000 $9.48 a 2,238,686 direct -3.2407 -5.1852 -21.5741 0.0 1 -23.4259 29

WALKEY CARL - Officer SENIOR VICE PRESIDENT

2021-05-26 19:37:45 -0400 2021-05-26 S 600 $10.00 d 1,354,939 direct yes 0.3 -1.4 -9.1 8.0 8 -11.1 29

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
NEOLEUKIN THERAPEUTICS INC NLTX 2021-07-23 22:15:03 UTC -0.3049 0.3849 400000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-07-23 21:45:03 UTC -0.3049 0.3849 400000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-07-23 21:15:03 UTC -0.3049 0.3849 400000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-07-23 20:45:03 UTC -0.3085 0.3885 400000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-07-23 20:15:05 UTC -0.3085 0.3885 400000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-07-23 19:45:03 UTC -0.3085 0.3885 400000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-07-23 19:15:03 UTC -0.3085 0.3885 400000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-07-23 18:45:03 UTC -0.307 0.387 400000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-07-23 18:15:03 UTC -0.307 0.387 400000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-07-23 17:45:03 UTC -0.307 0.387 400000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-07-23 17:15:02 UTC -0.307 0.387 400000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-07-23 16:45:02 UTC -0.2946 0.3746 400000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-07-23 16:15:03 UTC -0.2946 0.3746 400000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-07-23 15:45:02 UTC -0.2946 0.3746 400000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-07-23 15:15:03 UTC -0.2946 0.3746 400000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-07-23 14:45:03 UTC -0.3164 0.3964 400000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-07-23 14:15:03 UTC -0.3164 0.3964 400000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-07-23 13:45:03 UTC -0.3164 0.3964 400000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-07-23 13:15:03 UTC -0.3164 0.3964 400000
NEOLEUKIN THERAPEUTICS INC NLTX 2021-07-23 12:45:03 UTC -0.3164 0.3964 400000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments